Novo Nordisk A/S
NVO
|
$123.64
-0.21%
1.4M
|
Health Technology
(0.0% 1d) (-6.8% 1m) (-27.6% 1y) (0.0% 2d) (0.0% 3d) (-0.8% 7d) (-13.35% volume)
Earnings Calendar:
Market Cap: $ 424,719,225,920
http://www.novonordisk.com
Sec Filling | Patents | 43258 employees
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
obesity diabetes haemophilia insulin diabetic hormone growth hormone
add to watch list Paper trade email alert is off
Press-releases
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
repurchase
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
conference therapeutics
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 1.1%
H: 0.46%
C: -2.32%
business natural million food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
investments update asia
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: -1.96%
H: 1.3%
C: 1.13%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
repurchase
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published: 2024-03-25 (Crawled : 10:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
disease pipeline pharmaceuticals acquire cardiovascular
Novo Nordisk A/S - Articles of Association 2024
Published: 2024-03-25 (Crawled : 08:00) - globenewswire.com
NVO | $123.64 -0.21% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
association
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Last 48 Hours Insiders Buying
TPL P 12 | $588.26 0.75% 12K
|
Miscellaneous
|
16:01
HNRA | $2.617 10.89% 260K
|
n/a
|
15:02
TGEN | $0.67 16K
|
Utilities
|
14:30
RMCF | $3.6492 9.1K
|
Consumer Non-Durables
|
20:10